Samsung Biologics Stock Price at 770,000 Won... Down 1.41% from Previous Day

Samsung Biologics ranked among the top searched stocks on 4 days within the past month.

As of 2:31 PM on the 6th, Samsung Biologics is trading at 770,000 KRW, down 1.41% from the previous day. This represents a 22.22% increase compared to October 26. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have net sold 4,000 shares of Samsung Biologics, while institutions have net bought 1,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 344,417 shares, whereas foreigners and institutions have net bought 77,683 shares and 266,579 shares, respectively.

On November 5, Samsung Biologics was a market topic with the headline "Strong performance due to US therapeutic drug favorable news."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.